IBDEI02B ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2644,1,5,0)
 ;;=5^Heart Failure, Chronic Systolic
 ;;^UTILITY(U,$J,358.3,2644,2)
 ;;=Heart Failure, Chronic Systolic^328495
 ;;^UTILITY(U,$J,358.3,2645,0)
 ;;=428.23^^32^201^51
 ;;^UTILITY(U,$J,358.3,2645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2645,1,4,0)
 ;;=4^428.23
 ;;^UTILITY(U,$J,358.3,2645,1,5,0)
 ;;=5^Heart Failure, Systolic, Acute on Chronic
 ;;^UTILITY(U,$J,358.3,2645,2)
 ;;=Heart Failure, Systolic, Acute on Chronic^328496
 ;;^UTILITY(U,$J,358.3,2646,0)
 ;;=428.30^^32^201^47
 ;;^UTILITY(U,$J,358.3,2646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2646,1,4,0)
 ;;=4^428.30
 ;;^UTILITY(U,$J,358.3,2646,1,5,0)
 ;;=5^Heart Failure, Diastolic
 ;;^UTILITY(U,$J,358.3,2646,2)
 ;;=Heart Failure, Diastolic^328595
 ;;^UTILITY(U,$J,358.3,2647,0)
 ;;=428.31^^32^201^43
 ;;^UTILITY(U,$J,358.3,2647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2647,1,4,0)
 ;;=4^428.31
 ;;^UTILITY(U,$J,358.3,2647,1,5,0)
 ;;=5^Heart Failure, Acute Diastolic
 ;;^UTILITY(U,$J,358.3,2647,2)
 ;;=Heart Failure, Acute Diastolic^328497
 ;;^UTILITY(U,$J,358.3,2648,0)
 ;;=428.32^^32^201^45
 ;;^UTILITY(U,$J,358.3,2648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2648,1,4,0)
 ;;=4^428.32
 ;;^UTILITY(U,$J,358.3,2648,1,5,0)
 ;;=5^Heart Failure, Chronic Diastolic
 ;;^UTILITY(U,$J,358.3,2648,2)
 ;;=Heart Failure, Chronic Diastolic^328498
 ;;^UTILITY(U,$J,358.3,2649,0)
 ;;=428.33^^32^201^49
 ;;^UTILITY(U,$J,358.3,2649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2649,1,4,0)
 ;;=4^428.33
 ;;^UTILITY(U,$J,358.3,2649,1,5,0)
 ;;=5^Heart Failure, Diastolic, Acute on Chronic
 ;;^UTILITY(U,$J,358.3,2649,2)
 ;;=Heart Failure, Diastolic, Acute on Chronic^328499
 ;;^UTILITY(U,$J,358.3,2650,0)
 ;;=428.40^^32^201^48
 ;;^UTILITY(U,$J,358.3,2650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2650,1,4,0)
 ;;=4^428.40
 ;;^UTILITY(U,$J,358.3,2650,1,5,0)
 ;;=5^Heart Failure, Diastolic& Systolic
 ;;^UTILITY(U,$J,358.3,2650,2)
 ;;=Heart Failure, Systolic and Diastolic^328596
 ;;^UTILITY(U,$J,358.3,2651,0)
 ;;=428.41^^32^201^50
 ;;^UTILITY(U,$J,358.3,2651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2651,1,4,0)
 ;;=4^428.41
 ;;^UTILITY(U,$J,358.3,2651,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute
 ;;^UTILITY(U,$J,358.3,2651,2)
 ;;=Heart Failure, Systolic & Diastolic, Acute^328500
 ;;^UTILITY(U,$J,358.3,2652,0)
 ;;=428.42^^32^201^54
 ;;^UTILITY(U,$J,358.3,2652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2652,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,2652,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,2652,2)
 ;;=^328501
 ;;^UTILITY(U,$J,358.3,2653,0)
 ;;=428.43^^32^201^53
 ;;^UTILITY(U,$J,358.3,2653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2653,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,2653,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic
 ;;^UTILITY(U,$J,358.3,2653,2)
 ;;=^328502
 ;;^UTILITY(U,$J,358.3,2654,0)
 ;;=396.3^^32^201^12
 ;;^UTILITY(U,$J,358.3,2654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2654,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,2654,1,5,0)
 ;;=5^Aortic and Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,2654,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,2655,0)
 ;;=429.9^^32^201^30
 ;;^UTILITY(U,$J,358.3,2655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2655,1,4,0)
 ;;=4^429.9
 ;;^UTILITY(U,$J,358.3,2655,1,5,0)
 ;;=5^Diastolic Dysfunction
 ;;^UTILITY(U,$J,358.3,2655,2)
 ;;=^54741
 ;;^UTILITY(U,$J,358.3,2656,0)
 ;;=453.79^^32^201^29
 ;;^UTILITY(U,$J,358.3,2656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2656,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,2656,1,5,0)
 ;;=5^Chr Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,2656,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,2657,0)
 ;;=453.89^^32^201^1
 ;;^UTILITY(U,$J,358.3,2657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2657,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,2657,1,5,0)
 ;;=5^AC Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,2657,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,2658,0)
 ;;=454.0^^32^201^84
 ;;^UTILITY(U,$J,358.3,2658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2658,1,4,0)
 ;;=4^454.0
 ;;^UTILITY(U,$J,358.3,2658,1,5,0)
 ;;=5^Varicose Veins
 ;;^UTILITY(U,$J,358.3,2658,2)
 ;;=^125410
 ;;^UTILITY(U,$J,358.3,2659,0)
 ;;=454.2^^32^201^85
 ;;^UTILITY(U,$J,358.3,2659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2659,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,2659,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,2659,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,2660,0)
 ;;=426.10^^32^201^3
 ;;^UTILITY(U,$J,358.3,2660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2660,1,4,0)
 ;;=4^426.10
 ;;^UTILITY(U,$J,358.3,2660,1,5,0)
 ;;=5^AV CONDUCTION ABNORMAL
 ;;^UTILITY(U,$J,358.3,2660,2)
 ;;=^11396
 ;;^UTILITY(U,$J,358.3,2661,0)
 ;;=396.8^^32^201^2
 ;;^UTILITY(U,$J,358.3,2661,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2661,1,4,0)
 ;;=4^396.8
 ;;^UTILITY(U,$J,358.3,2661,1,5,0)
 ;;=5^AORTIC/MITRAL STENOSIS/REGURG
 ;;^UTILITY(U,$J,358.3,2661,2)
 ;;=^269584
 ;;^UTILITY(U,$J,358.3,2662,0)
 ;;=414.00^^32^201^18
 ;;^UTILITY(U,$J,358.3,2662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2662,1,4,0)
 ;;=4^414.00
 ;;^UTILITY(U,$J,358.3,2662,1,5,0)
 ;;=5^CAD
 ;;^UTILITY(U,$J,358.3,2662,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,2663,0)
 ;;=425.4^^32^201^20
 ;;^UTILITY(U,$J,358.3,2663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2663,1,4,0)
 ;;=4^425.4
 ;;^UTILITY(U,$J,358.3,2663,1,5,0)
 ;;=5^CARDIOMYOPATHY
 ;;^UTILITY(U,$J,358.3,2663,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,2664,0)
 ;;=410.90^^32^201^61
 ;;^UTILITY(U,$J,358.3,2664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2664,1,4,0)
 ;;=4^410.90
 ;;^UTILITY(U,$J,358.3,2664,1,5,0)
 ;;=5^MYOCARDIAL INFARCTION
 ;;^UTILITY(U,$J,358.3,2664,2)
 ;;=^269673
 ;;^UTILITY(U,$J,358.3,2665,0)
 ;;=427.2^^32^201^66
 ;;^UTILITY(U,$J,358.3,2665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2665,1,4,0)
 ;;=4^427.2
 ;;^UTILITY(U,$J,358.3,2665,1,5,0)
 ;;=5^PAROX ATR TACHYCARDIA
 ;;^UTILITY(U,$J,358.3,2665,2)
 ;;=^117073
 ;;^UTILITY(U,$J,358.3,2666,0)
 ;;=272.4^^32^201^57
 ;;^UTILITY(U,$J,358.3,2666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2666,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,2666,1,5,0)
 ;;=5^Hyperlipidemia, NOS
 ;;^UTILITY(U,$J,358.3,2666,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,2667,0)
 ;;=271.3^^32^202^11
 ;;^UTILITY(U,$J,358.3,2667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2667,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,2667,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,2667,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,2668,0)
 ;;=611.1^^32^202^16
 ;;^UTILITY(U,$J,358.3,2668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2668,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,2668,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,2668,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,2669,0)
 ;;=704.1^^32^202^17
 ;;^UTILITY(U,$J,358.3,2669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2669,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,2669,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,2669,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,2670,0)
 ;;=251.2^^32^202^28
 ;;^UTILITY(U,$J,358.3,2670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2670,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,2670,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,2670,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,2671,0)
 ;;=257.2^^32^202^29
 ;;^UTILITY(U,$J,358.3,2671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2671,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,2671,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,2671,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,2672,0)
 ;;=253.2^^32^202^32
 ;;^UTILITY(U,$J,358.3,2672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2672,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,2672,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,2672,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,2673,0)
 ;;=733.00^^32^202^41
 ;;^UTILITY(U,$J,358.3,2673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2673,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,2673,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,2673,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,2674,0)
 ;;=278.00^^32^202^38
 ;;^UTILITY(U,$J,358.3,2674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2674,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,2674,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,2674,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,2675,0)
 ;;=278.01^^32^202^37
 ;;^UTILITY(U,$J,358.3,2675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2675,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,2675,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,2675,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,2676,0)
 ;;=250.80^^32^202^9
 ;;^UTILITY(U,$J,358.3,2676,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2676,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,2676,1,5,0)
 ;;=5^DM Type II with LE Ulcer
 ;;^UTILITY(U,$J,358.3,2676,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,2677,0)
 ;;=250.00^^32^202^4
 ;;^UTILITY(U,$J,358.3,2677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2677,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,2677,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,2677,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,2678,0)
 ;;=250.40^^32^202^5
 ;;^UTILITY(U,$J,358.3,2678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2678,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,2678,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,2678,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,2679,0)
 ;;=250.50^^32^202^8
 ;;^UTILITY(U,$J,358.3,2679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2679,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,2679,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,2679,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,2680,0)
 ;;=250.60^^32^202^6
 ;;^UTILITY(U,$J,358.3,2680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2680,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,2680,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,2680,2)
 ;;=^267841^357.2
